Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) featuring a modified N-terminal structure designed to enhance stability. In laboratory and cellular models, research focuses on its selective binding to pituitary GHRH receptors to stimulate the endogenous release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Researchers investigate its mechanism of action regarding lipid metabolism, visceral adipose tissue reduction, and metabolic signaling pathways.
This website offers products strictly for Laboratory Research Use Only. Not for human consumption, medical, or veterinary use.